Home Cart 0 Sign in  

[ CAS No. 250612-42-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 250612-42-1
Chemical Structure| 250612-42-1
Structure of 250612-42-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 250612-42-1 ]

Related Doc. of [ 250612-42-1 ]

Alternatived Products of [ 250612-42-1 ]

Product Details of [ 250612-42-1 ]

CAS No. :250612-42-1 MDL No. :MFCD20134101
Formula : C31H43F6N9O12 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 847.72 Pubchem ID :-
Synonyms :
Cyclo(RGDyK)
Chemical Name :2,2,2-Trifluoroacetic acid compound with 2-((2S,5R,8S,11S)-8-(4-aminobutyl)-11-(3-guanidinopropyl)-5-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid (2:1)

Calculated chemistry of [ 250612-42-1 ]

Physicochemical Properties

Num. heavy atoms : 58
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.52
Num. rotatable bonds : 15
Num. H-bond acceptors : 20.0
Num. H-bond donors : 13.0
Molar Refractivity : 203.0
TPSA : 365.55 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -13.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.51
Log Po/w (XLOGP3) : -2.83
Log Po/w (WLOGP) : -1.25
Log Po/w (MLOGP) : -2.81
Log Po/w (SILICOS-IT) : -1.36
Consensus Log Po/w : -1.55

Druglikeness

Lipinski : 3.0
Ghose : None
Veber : 2.0
Egan : 1.0
Muegge : 5.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : -2.4
Solubility : 3.38 mg/ml ; 0.00399 mol/l
Class : Soluble
Log S (Ali) : -4.29
Solubility : 0.0434 mg/ml ; 0.0000512 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.5
Solubility : 0.00267 mg/ml ; 0.00000315 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 6.31

Safety of [ 250612-42-1 ]

Signal Word:Danger Class:9
Precautionary Statements:P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501 UN#:3077
Hazard Statements:H302-H319-H332-H372-H400 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 250612-42-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 250612-42-1 ]

[ 250612-42-1 ] Synthesis Path-Downstream   1~8

  • 2
  • [ CAS Unavailable ]
  • [ 250612-42-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: N-[3-(N,N-dimethylamino)-propyl]-N'-ethyl-carbodiimide hydrochloride / dichloromethane / 3.5 h / 20 °C 2: dichloromethane / 2 h
  • 3
  • cyclo(Arg-Gly-Asp-D-Tyr-Lys)* 2TFA [ No CAS ]
  • [ 59156-70-6 ]
  • C37H52N10O13*C2HF3O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
43% With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 24h; 8.8-1 (Preparation of compound IV) A DMF solution (680 mL) of compound II (28.8 mg, 0.034 mmol) and compound III (23.2 mg, 0.068 mmol) was stirred, and DIEA (16.8 µL, 0.10 mmol) was added. After stirring the solution at room temperature for 24 hours, and the mixture was directly purified with a reverse phase HPLC with the same condition as that employed in the preparation of compound I to obtain the target compound (14.0 mg, 43%). 1H NMR (500 MHz, CD3OD, 25°C) δ7.00 (d, J = 6.5 Hz, 2H), 6.68 (d, J = 6.5 Hz, 2H), 4.74 (t, J = 7.0 Hz, 1H), 4.41 (q, J = 7.0 Hz, 1H), 4.26-4.30 (m, 2H), 3.91-3.86 (m, 1H), 3.22-3.18 (m, 1H), 3.14-3.10 (m, 1H), 3.09 (t, J = 6.5 Hz, 2H), 2.91-2.85 (m, 2H), 2.84-2.78 (m, 5H), 2.59 (t, J = 9.5 Hz, 2H), 2.64-2.60 (m, 1H), 2.58 (dd, J = 16.5, 9.0 Hz, 1H), 2.19 (t, J = 7.0 Hz, 2H), 2.22 (t, J = 7.0 Hz, 2H), 1.92-1.82 (m, 1H), 1.74-1.60 (m, 6H), 1.57-1.44 (m, 3H), 1.44-1.32 (m, 2H), 1.09-0.90 (m, 2H); ESI-HRMS m/z calcd for C37H53N10O13 ([M+H]+) 845.3788, found 845.3769.
43% With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 24h; 8.8-1 (Preparation of compound IV) A DMF solution (680 mL) of compound II (28.8 mg, 0.034 mmol) and compound III (23.2 mg, 0.068 mmol) was stirred, and DIEA (16.8 µL, 0.10 mmol) was added. After stirring the solution at room temperature for 24 hours, and the mixture was directly purified with a reverse phase HPLC with the same condition as that employed in the preparation of compound I to obtain the target compound (14.0 mg, 43%). 1H NMR (500 MHz, CD3OD, 25°C) δ7.00 (d, J = 6.5 Hz, 2H), 6.68 (d, J = 6.5 Hz, 2H), 4.74 (t, J = 7.0 Hz, 1H), 4.41 (q, J = 7.0 Hz, 1H), 4.26-4.30 (m, 2H), 3.91-3.86 (m, 1H), 3.22-3.18 (m, 1H), 3.14-3.10 (m, 1H), 3.09 (t, J = 6.5 Hz, 2H), 2.91-2.85 (m, 2H), 2.84-2.78 (m, 5H), 2.59 (t, J = 9.5 Hz, 2H), 2.64-2.60 (m, 1H), 2.58 (dd, J = 16.5, 9.0 Hz, 1H), 2.19 (t, J = 7.0 Hz, 2H), 2.22 (t, J = 7.0 Hz, 2H), 1.92-1.82 (m, 1H), 1.74-1.60 (m, 6H), 1.57-1.44 (m, 3H), 1.44-1.32 (m, 2H), 1.09-0.90 (m, 2H); ESI-HRMS m/z calcd for C37H53N10O13 ([M+H]+) 845.3788, found 845.3769.
  • 4
  • [ 1448588-46-2 ]
  • [ 76-05-1 ]
  • [ 250612-42-1 ]
YieldReaction ConditionsOperation in experiment
54.5 mg In dichloromethane for 2h; 8.8-1 Subsequently, this protected peptide obtained was dissolved in a solution of TFA/methylene chloride (1:1) for 2 hours to perform deprotection. The mixture was concentrated under reduced pressure, and directly purified by a reverse phase HPLC with a linear gradient condition of 20 - 80% acetonitrile aqueous solution (0.1% TFA) over 40 minutes. Yield: 54.5 mg, 77% (2-step yield). ESI-HRMS m/z calcd for C27H41N9O8 ([M+H]+) 620.3151, found 620.3169.
54.5 mg In dichloromethane for 2h; 8.8-1 Subsequently, this protected peptide obtained was dissolved in a solution of TFA/methylene chloride (1:1) for 2 hours to perform deprotection. The mixture was concentrated under reduced pressure, and directly purified by a reverse phase HPLC with a linear gradient condition of 20 - 80% acetonitrile aqueous solution (0.1% TFA) over 40 minutes. Yield: 54.5 mg, 77% (2-step yield). ESI-HRMS m/z calcd for C27H41N9O8 ([M+H]+) 620.3151, found 620.3169.
  • 5
  • [ 250612-42-1 ]
  • [ CAS Unavailable ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
56 % With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;
  • 6
  • [ 250612-42-1 ]
  • [ CAS Unavailable ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
45 % With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;
  • 7
  • [ 250612-42-1 ]
  • [ CAS Unavailable ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
88 % With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;
  • 8
  • [ 250612-42-1 ]
  • [ CAS Unavailable ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
3.5 mg With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;
Same Skeleton Products
Historical Records

Similar Product of
[ 250612-42-1 ]

Chemical Structure| 217099-14-4

A1219111[ 217099-14-4 ]

Cyclo(L-arginylglycyl-L-α-aspartyl-D-tyrosyl-L-lysyl)

Reason: Salt